\-\ Texto\\:\\ \ \(0\)\
\-\ bp\\:\\ 111\\/63\\,\\ hr\\:\\ 98\\,\\ rr\\:\\ 18\\,\\ t\\:\\ 97\\.6\\ \\¬\\∞f\\,\\ ht\\:\\ 63\\ in\\,\\ wt\\:\\ 158\\ lbs\\,\\ bmi\\:\\ 27\\.99\\.\ \(0\)\
\-\ no\\ focal\\ neurological\\ findings\\ found\\ on\\ exam\ \(0\)\
\-\ csf\\:\\ large\\ amount\\ of\\ rbc\\ with\\ xanthochromia\ \(0\)\
\-\ esr\\:\\ 56\\ mm\\/hour\ \(0\)\
\-\ no\\ proteinuria\\ on\\ ua\ \(0\)\
\-\ otherwise\\ normal\\ exam\\ and\\ labs\ \(0\)\
\-\ cerebral\\ vasculitis\\ is\\ a\\ highly\\ treatable\\ condition\\;\\ there\\ currently\\ is\\ no\\ standard\\ management\\ that\\ has\\ been\\ established\\,\\ but\\ most\\ authors\\ agree\\ that\\ acute\\-phase\\ treatment\\ includes\\ cessation\\ of\\ vasoconstrictors\\,\\ treatment\\ of\\ associated\\ conditions\\,\\ vasospasm\\ treatment\\ \\(calcium\\ channel\\ antagonists\\)\\,\\ corticosteroids\\,\\ headache\\ relief\\,\\ blood\\ pressure\\ control\\,\\ and\\ stroke\\,\\ cerebral\\ edema\\,\\ and\\ seizure\\ treatment\\ as\\ needed\\.\\ \\ a\\ high\\ dose\\ intravenous\\ steroids\\ \\‚\\Ä\\ì\\ probably\\ best\\ as\\ intravenous\\ methyl\\ prednisolone\\ 1\\ gram\\ daily\\ for\\ 3\\ days\\.\\ \\ other\\ treatments\\ including\\ azathioprine\\ \\(2\\ mg\\/kg\\/day\\)\\ for\\ 10\\ months\\,\\ methotrexate\\ 10\\‚\\Ä\\ì25\\ mg\\ on\\ a\\ weekly\\ basis\\,\\ intravenous\\ immunoglobulin\\ \\(0\\.4\\ mg\\/kg\\/day\\ for\\ 5\\ days\\)\\,\\ plasmapheresis\\,\\ and\\ campath\\-1h\\ may\\ be\\ used\\ depending\\ upon\\ the\\ etiology\\.\\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ \\‚\\Ä\\¢\\ calado\\ s\\,\\ viana\\-baptista\\ m\\.\\ \\‚\\Ä\\úbenign\\ cerebral\\ angiopathy\\;\\ postpartum\\ cerebral\\ angiopathy\\:\\ characteristics\\ and\\ treatment\\‚\\Ä\\ù\\.\\ curr\\ treat\\ options\\ cardiovasc\\ med\\.\\ 2006\\ may\\;8\\(3\\)\\:201\\-12\\.\ \(0\)\
\-\ \\‚\\Ä\\¢\\ joseph\\ f\\,\\ scolding\\ n\\.\\ \\‚\\Ä\\úcerebral\\ vasculitis\\ a\\ practical\\ approach\\‚\\Ä\\ù\\ practical\\ neurology\\ 2002\\,\\ 2\\,\\ 80\\‚\\Ä\\ì93\\.\\ pn\\.bmj\\.com\\/cgi\\/reprint\\/2\\/2\\/80\\.pdf\ \(0\)\
\-\ ct\\:\\ \\ axial\\ noncontrast\\ ct\\ of\\ the\\ brain\\ showed\\ an\\ acute\\ sah\\ in\\ the\\ right\\ frontal\\ lobe\\ brain\\.\\ \\ \ \(0\)\
\-\ cerebral\\ angiogram\\:\\ \\ lateral\\ projection\\ of\\ the\\ right\\ cerebral\\ angiogram\\ demonstrated\\ irregular\\ variable\\ caliber\\ in\\ cortical\\ vessels\\ in\\ the\\ right\\ mca\\ distribution\\.\\ \\ \ \(0\)\
\-\ mri\\/mra\\:\\ \\ diffusion\\ weight\\ image\\,\\ apparent\\ diffusion\\ coefficient\\ mri\\,\\ and\\ t2\\-weighted\\ images\\ of\\ brain\\ demonstrate\\ an\\ acute\\ infarct\\ in\\ the\\ right\\ mid\\-posterior\\ cerebellar\\ in\\ the\\ superior\\ cerebellar\\ vascular\\ territory\\.\\ \\ \ \(0\)\
\-\ axial\\ flair\\ mri\\ of\\ the\\ brain\\ showed\\ multiple\\ nonspecific\\ small\\ foci\\ of\\ increased\\ flair\\ signal\\ within\\ the\\ anterior\\ aspects\\ of\\ the\\ external\\ capsule\\ bilaterally\\.\\ \\ \ \(0\)\
\-\ 3d\\ time\\ of\\ flight\\ mra\\ of\\ the\\ cerebral\\ arteries\\ demonstrated\\ mca\\ cortical\\ vessel\\ caliber\\ variation\\.\ \(0\)\
\-\ postpartum\\ cerebral\\ angiopathy\ \(4\)\
\-\ postpartum\\ cerebral\\ angiopathy\\ \ \(2\)\
\-\ preeclampsia\\ \ \(1\)\
\-\ pseudoanyeurysm\\ \ \(0\)\
\-\ primary\\ cerebral\\ vasculitis\\ \ \(0\)\
\-\ other\\ secondary\\ cerebral\\ vasculitis\\:\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ polyarteritis\\ nodosa\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ giant\\ cell\\ arteritis\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ takayasu\\‚\\Ä\\ôs\\ arteritis\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ wegener\\‚\\Ä\\ôs\\ granulomatosis\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ sle\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ ra\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ behcet\\‚\\Ä\\ôs\\ syndrome\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ lyme\\ disease\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ illicit\\ drugs\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\&\\#61607\\;\\	cocaine\\ \ \(1\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\&\\#61607\\;\\	heroin\\ \ \(1\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\&\\#61607\\;\\	amphetamines\\ \ \(1\)\
\-\ \\‚\\Ä\\¢\\ sarcoidosis\ \(1\)\
\-\ 34\\-year\\-old\\ african\\ american\\ g1p1\\ female\\ with\\ no\\ significant\\ medical\\ history\\ presents\\ to\\ the\\ er\\ four\\ days\\ postpartum\\ complaining\\ of\\ the\\ \\‚\\Ä\\úworst\\ headache\\ of\\ her\\ life\\‚\\Ä\\ù\\ on\\ the\\ right\\-sided\\ of\\ her\\ head\\.\ \(0\)\
\-\ postpartum\\ cerebral\\ angiopathy\\ is\\ a\\ rare\\ ailment\\ that\\ affects\\ females\\ who\\ are\\ otherwise\\ healthy\\ and\\ recently\\ had\\ a\\ normal\\ pregnancy\\ and\\ uncomplicated\\ delivery\\.\\ \\ like\\ primary\\ and\\ other\\ secondary\\ cerebral\\ vasculitis\\,\\ postpartum\\ cerebral\\ angiopathy\\ may\\ cause\\ ischemic\\ or\\ hemorrhagic\\ stroke\\,\\ and\\ neurological\\ deficits\\.\\ \\ more\\ commonly\\,\\ secondary\\ cerebral\\ angiopathy\\ occurs\\ in\\ the\\ setting\\ of\\ other\\ medical\\ conditions\\ such\\ as\\ infections\\,\\ systemic\\ vasculitis\\ \\(wegener\\‚\\Ä\\ôs\\ granulomatosis\\ \\&\\ polyarteritis\\)\\,\\ connective\\ tissue\\ diseases\\ \\(systemic\\ lupus\\ erythematosus\\ \\&\\ rheumatoid\\ arthritis\\)\\,\\ medications\\,\\ illicit\\ drugs\\,\\ carcinomas\\ \\(lymphoma\\ \\&\\ leukemia\\)\\,\\ and\\ behcet\\‚\\Ä\\ôs\\ disease\\.\\ \\ other\\ conditions\\,\\ therefore\\,\\ need\\ to\\ be\\ ruled\\ out\\ before\\ a\\ diagnosis\\ of\\ postpartum\\ cerebral\\ angiopathy\\ can\\ be\\ made\\ including\\ preeclampsia\\ \\/eclampsia\\.\\ \ \(0\)\
\-\ \\ \\ contrast\\ catheter\\ angiography\\ and\\ magnetic\\ resonance\\ imaging\\/angiography\\ \\(mri\\/mra\\)\\ are\\ the\\ typical\\ imaging\\ modalities\\ used\\ to\\ help\\ with\\ the\\ diagnosis\\ of\\ cerebral\\ vasculitis\\ although\\,\\ single\\ photon\\ emission\\ computed\\ tomography\\ \\(spect\\)\\ and\\ indium\\-labelled\\ white\\ cell\\ nuclear\\ scanning\\ may\\ provide\\ some\\ benefit\\.\\ \\ definitive\\ diagnosis\\ of\\ cerebral\\ vasculitis\\ is\\ typically\\ made\\ by\\ biopsy\\ of\\ brain\\.\\ \ \(0\)\
\-\ \\ \\ in\\ this\\ patient\\ she\\ presented\\ to\\ the\\ er\\ with\\ the\\ \\‚\\Ä\\úworse\\ headache\\ of\\ her\\ life\\‚\\Ä\\ù\\ on\\ the\\ right\\ side\\ 4\\ days\\ postpartum\\.\\ \\ noncontrast\\ computed\\ tomography\\ \\(ct\\)\\ showed\\ subarachnoid\\ hemorrhage\\ \\(sah\\)\\ with\\ the\\ right\\ sylvian\\ fissure\\ and\\ the\\ sulci\\ of\\ the\\ right\\ frontal\\ lobe\\.\\ \\ further\\ vascular\\ studies\\ including\\ a\\ ct\\ angiogram\\ \\(cta\\)\\,\\ contrast\\ angiography\\,\\ and\\ mra\\ showed\\ no\\ evidence\\ of\\ an\\ intracerebral\\ aneurysm\\.\\ \\ the\\ patient\\ had\\ no\\ history\\ of\\ hypertension\\ and\\ was\\ not\\ hypertensive\\ during\\ the\\ headache\\.\\ \\ she\\ was\\ tested\\ several\\ times\\ throughout\\ pregnancy\\ with\\ no\\ evidence\\ of\\ elevated\\ blood\\ pressure\\,\\ proteinuria\\,\\ or\\ headaches\\ looking\\ for\\ preeclampsia\\.\\ \\ the\\ patient\\ had\\ an\\ elevated\\ erythrocyte\\ sedimentation\\ rate\\ \\(esr\\)\\ of\\ 56\\ mm\\/hour\\.\\ \\ \ \(0\)\
\-\ upon\\ further\\ investigation\\ the\\ patient\\ had\\ a\\ contrast\\ enhanced\\ angiogram\\ which\\ showed\\ irregular\\ variable\\ caliber\\ vessels\\ with\\ \\‚\\Ä\\úsausage\\ linked\\‚\\Ä\\ù\\ appearance\\ in\\ the\\ cortical\\ branches\\ of\\ both\\ the\\ middle\\ cerebral\\ arteries\\ with\\ a\\ more\\ prominence\\ on\\ the\\ right\\ side\\ as\\ opposed\\ to\\ the\\ left\\.\\ \\ the\\ mri\\ also\\ showed\\ and\\ acute\\ 5\\ mm\\ left\\ cerebellar\\ infarct\\ located\\ within\\ a\\ superior\\ cerebellar\\ artery\\ vascular\\ territory\\ and\\ multiple\\ nonspecific\\ small\\ foci\\ of\\ increased\\ flair\\ signal\\ within\\ the\\ anterior\\ aspects\\ of\\ the\\ external\\ capsule\\ bilaterally\\.\\ \\ \ \(0\)\
\-\ this\\ patient\\ had\\ several\\ classic\\ imaging\\ findings\\ of\\ cerebral\\ vasculopathy\\ of\\ small\\ vessel\\ ischemic\\ disease\\,\\ sah\\,\\ and\\ cortical\\ enhancement\\.\\ \\ she\\ had\\ no\\ known\\ significant\\ past\\ medical\\ history\\ including\\ autoimmune\\ disorders\\,\\ systemic\\ vasculitis\\,\\ or\\ connective\\ tissue\\ disorders\\.\\ \\ she\\ had\\ a\\ normal\\ uncomplicated\\ pregnancy\\ and\\ developed\\ her\\ first\\ symptoms\\ 4\\ days\\ postpartum\\ fitting\\ the\\ description\\ of\\ postpartum\\ cerebral\\ angiopathy\\.\\ \\ \ \(0\)\
\-\ the\\ patient\\ was\\ treated\\ with\\ oral\\ prednisolone\\ and\\ was\\ felt\\ that\\ a\\ brain\\ biopsy\\ was\\ not\\ necessary\\ in\\ this\\ case\\ to\\ make\\ the\\ definitive\\ diagnosis\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ \\‚\\Ä\\¢\\ brant\\ w\\,\\ helms\\ c\\.\\ \\‚\\Ä\\úfundamentals\\ of\\ diagnostic\\ radiology\\‚\\Ä\\ù\\ lippincott\\ williams\\ \\&\\ wilkins\\,\\ philadelphia\\,\\ pa\\ 2007\\.\ \(0\)\
\-\ \\‚\\Ä\\¢\\ singhal\\ a\\,\\ bernstein\\ r\\.\\ \\‚\\Ä\\úpostpartum\\ angiopathy\\ and\\ other\\ cerebral\\ vasoconstriction\\ syndromes\\‚\\Ä\\ù\\.\\ neurocrit\\ care\\.\\ 2005\\;3\\(1\\)\\:91\\-7\\.\ \(0\)\
\-\ \\‚\\Ä\\¢\\ wilhelm\\ k\\.\\ \\‚\\Ä\\úimaging\\ of\\ cerebral\\ vasculitis\\‚\\Ä\\ù\\ \\‚\\Ä\\úinternational\\ journal\\ of\\ stroke\\‚\\Ä\\ù\\ vol\\ 2\\(3\\)\\,\\ 184\\ \\‚\\Ä\\ì190\\.\ \(0\)\
\-\ \\‚\\Ä\\¢\\ amos\\ p\\.\\ postpartum\\ cerebral\\ angiopathy\\:\\ a\\ case\\ study\\.\\ j\\ neurosci\\ nurs\\.\\ 2007\\ feb\\;39\\(1\\)\\:9\\-12\\.\ \(0\)\
\-\ \\‚\\Ä\\¢\\ joseph\\ f\\,\\ scolding\\ n\\.\\ \\‚\\Ä\\úcerebral\\ vasculitis\\ a\\ practical\\ approach\\‚\\Ä\\ù\\ practical\\ neurology\\ 2002\\,\\ 2\\,\\ 80\\‚\\Ä\\ì93\\.\\ pn\\.bmj\\.com\\/cgi\\/reprint\\/2\\/2\\/80\\.pdf\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cerebral\\:\\ 0\\.41269017711631467\ \(0\)\
\-\ postpartum\\:\\ 0\\.34255883338963594\ \(0\)\
\-\ angiopathy\\:\\ 0\\.30595735498241583\ \(0\)\
\-\ vasculitis\\:\\ 0\\.2338818737171159\ \(0\)\
\-\ the\\:\\ 0\\.16914557718350642\ \(0\)\
\-\ of\\:\\ 0\\.15243934345983906\ \(0\)\
\-\ practical\\:\\ 0\\.11529467173596543\ \(0\)\
\-\ 61607\\:\\ 0\\.10991728494723263\ \(0\)\
\-\ and\\:\\ 0\\.10415245460015894\ \(0\)\
\-\ preeclampsia\\:\\ 0\\.10156555109233623\ \(0\)\
\-\ showed\\:\\ 0\\.09156062202437945\ \(0\)\
\-\ mra\\:\\ 0\\.09062907420189445\ \(0\)\
\-\ brain\\:\\ 0\\.08569458069607006\ \(0\)\
\-\ sah\\:\\ 0\\.0848620833825434\ \(0\)\
\-\ angiogram\\:\\ 0\\.08232392618761383\ \(0\)\
\-\ had\\:\\ 0\\.07990444929981615\ \(0\)\
\-\ cerebellar\\:\\ 0\\.07499577604647938\ \(0\)\
\-\ scolding\\:\\ 0\\.07327818996482176\ \(0\)\
\-\ days\\:\\ 0\\.07251711867220434\ \(0\)\
\-\ caliber\\:\\ 0\\.07213769941410984\ \(0\)\
\-\ other\\:\\ 0\\.07138716731418399\ \(0\)\
\-\ prednisolone\\:\\ 0\\.07002122255074326\ \(0\)\
\-\ right\\:\\ 0\\.06836241469540394\ \(0\)\
\-\ cortical\\:\\ 0\\.06579327135573461\ \(0\)\
\-\ including\\:\\ 0\\.06558394800327479\ \(0\)\
\-\ stroke\\:\\ 0\\.06391764998486818\ \(0\)\
\-\ angiography\\:\\ 0\\.06352683718464631\ \(0\)\
\-\ headache\\:\\ 0\\.06317445044893862\ \(0\)\
\-\ conditions\\:\\ 0\\.06278130013492439\ \(0\)\
\-\ intravenous\\:\\ 0\\.06266140854857084\ \(0\)\
\-\ polyarteritis\\:\\ 0\\.06119643256673382\ \(0\)\
\-\ behcet\\:\\ 0\\.06119643256673382\ \(0\)\
\-\ systemic\\:\\ 0\\.06099298674888591\ \(0\)\
\-\ mg\\:\\ 0\\.059996633849945746\ \(0\)\
\-\ no\\:\\ 0\\.05960222564968127\ \(0\)\
\-\ mri\\:\\ 0\\.05880143887185526\ \(0\)\
\-\ flair\\:\\ 0\\.05847167896205453\ \(0\)\
\-\ proteinuria\\:\\ 0\\.05824262075341784\ \(0\)\
\-\ her\\:\\ 0\\.057253063411723655\ \(0\)\
\-\ in\\:\\ 0\\.05699422748149943\ \(0\)\
\-\ pregnancy\\:\\ 0\\.05624683203485953\ \(0\)\
\-\ treatment\\:\\ 0\\.05456775855397048\ \(0\)\
\-\ she\\:\\ 0\\.05455262361971915\ \(0\)\
\-\ territory\\:\\ 0\\.05401668851944029\ \(0\)\
\-\ arteritis\\:\\ 0\\.05298984522981148\ \(0\)\
\-\ illicit\\:\\ 0\\.052674798183486894\ \(0\)\
\-\ wegener\\:\\ 0\\.05126192650191206\ \(0\)\
\-\ granulomatosis\\:\\ 0\\.05051992210355406\ \(0\)\
\-\ acute\\:\\ 0\\.04957511309976746\ \(0\)\
\-\ mm\\:\\ 0\\.049187961002456086\ \(0\)\
\-\ neurology\\:\\ 0\\.04844886594950934\ \(0\)\
\-\ imaging\\:\\ 0\\.04816125873776624\ \(0\)\
\-\ connective\\:\\ 0\\.04758430434107461\ \(0\)\
\-\ diagnosis\\:\\ 0\\.047506845733706254\ \(0\)\
\-\ mca\\:\\ 0\\.04742202265988054\ \(0\)\
\-\ aspects\\:\\ 0\\.04742202265988054\ \(0\)\
\-\ uncomplicated\\:\\ 0\\.04651169072812083\ \(0\)\
\-\ may\\:\\ 0\\.04611741827186176\ \(0\)\
\-\ drugs\\:\\ 0\\.045824719330337924\ \(0\)\
\-\ vascular\\:\\ 0\\.04537575005891068\ \(0\)\
\-\ 2007\\:\\ 0\\.045314537100947225\ \(0\)\
\-\ capsule\\:\\ 0\\.044834832195328064\ \(0\)\
\-\ patient\\:\\ 0\\.044710078942469506\ \(0\)\
\-\ variable\\:\\ 0\\.044492964856941\ \(0\)\
\-\ tomography\\:\\ 0\\.0443821676519077\ \(0\)\
\-\ 63\\:\\ 0\\.044272877938670185\ \(0\)\
\-\ noncontrast\\:\\ 0\\.044272877938670185\ \(0\)\
\-\ computed\\:\\ 0\\.04416505524580204\ \(0\)\
\-\ approach\\:\\ 0\\.043953656992532175\ \(0\)\
\-\ 2002\\:\\ 0\\.04385000819947746\ \(0\)\
\-\ medical\\:\\ 0\\.04368187743081763\ \(0\)\
\-\ joseph\\:\\ 0\\.043350924104699574\ \(0\)\
\-\ nonspecific\\:\\ 0\\.04306571059317063\ \(0\)\
\-\ 56\\:\\ 0\\.04279027778096165\ \(0\)\
\-\ esr\\:\\ 0\\.04193493112135234\ \(0\)\
\-\ definitive\\:\\ 0\\.0418542000899496\ \(0\)\
\-\ on\\:\\ 0\\.04151643236675333\ \(0\)\
\-\ secondary\\:\\ 0\\.040739135526183905\ \(0\)\
\-\ ischemic\\:\\ 0\\.04052467722373752\ \(0\)\
\-\ disorders\\:\\ 0\\.040456890576645956\ \(0\)\
\-\ with\\:\\ 0\\.04037570098179672\ \(0\)\
\-\ vessel\\:\\ 0\\.04019132357985193\ \(0\)\
\-\ was\\:\\ 0\\.039922917750214\ \(0\)\
\-\ that\\:\\ 0\\.03976942774698519\ \(0\)\
\-\ diffusion\\:\\ 0\\.0385972326758711\ \(0\)\
\-\ infarct\\:\\ 0\\.03812917776505717\ \(0\)\
\-\ neurological\\:\\ 0\\.037639228972082966\ \(0\)\
\-\ life\\:\\ 0\\.03759183845108345\ \(0\)\
\-\ foci\\:\\ 0\\.03745132168987127\ \(0\)\
\-\ external\\:\\ 0\\.03704394408664784\ \(0\)\
\-\ as\\:\\ 0\\.03681606271361312\ \(0\)\
\-\ vasoconstrictors\\:\\ 0\\.03663909498241088\ \(0\)\
\-\ methyl\\:\\ 0\\.03663909498241088\ \(0\)\
\-\ plasmapheresis\\:\\ 0\\.03663909498241088\ \(0\)\
\-\ calado\\:\\ 0\\.03663909498241088\ \(0\)\
\-\ coefficient\\:\\ 0\\.03663909498241088\ \(0\)\
\-\ pseudoanyeurysm\\:\\ 0\\.03663909498241088\ \(0\)\
\-\ ailment\\:\\ 0\\.03663909498241088\ \(0\)\
\-\ singhal\\:\\ 0\\.03663909498241088\ \(0\)\
\-\ neurocrit\\:\\ 0\\.03663909498241088\ \(0\)\
\-\ wilhelm\\:\\ 0\\.03663909498241088\ \(0\)\
\-\ amos\\:\\ 0\\.03663909498241088\ \(0\)\
\-\ nurs\\:\\ 0\\.03663909498241088\ \(0\)\
\-\ references\\:\\ 0\\.036531046282515196\ \(0\)\
\-\ arteries\\:\\ 0\\.036367108551421404\ \(0\)\
\-\ upon\\:\\ 0\\.036048941415715886\ \(0\)\
\-\ vessels\\:\\ 0\\.035557377667898266\ \(0\)\
\-\ small\\:\\ 0\\.0354542332928371\ \(0\)\
\-\ irregular\\:\\ 0\\.035376045588258936\ \(0\)\
\-\ made\\:\\ 0\\.035340265261792604\ \(0\)\
\-\ an\\:\\ 0\\.03504380154890359\ \(0\)\
\-\ xanthochromia\\:\\ 0\\.03501061127537163\ \(0\)\
\-\ antagonists\\:\\ 0\\.03501061127537163\ \(0\)\
\-\ ct\\:\\ 0\\.03488917725594823\ \(0\)\
\-\ pressure\\:\\ 0\\.03488906800671501\ \(0\)\
\-\ to\\:\\ 0\\.03436568431592888\ \(0\)\
\-\ used\\:\\ 0\\.034303431975305165\ \(0\)\
\-\ er\\:\\ 0\\.034272115483357804\ \(0\)\
\-\ sausage\\:\\ 0\\.03385518369744541\ \(0\)\
\-\ neurosci\\:\\ 0\\.03385518369744541\ \(0\)\
\-\ contrast\\:\\ 0\\.03339543109504426\ \(0\)\
\-\ agree\\:\\ 0\\.03295896444114105\ \(0\)\
\-\ curr\\:\\ 0\\.03295896444114105\ \(0\)\
\-\ cardiovasc\\:\\ 0\\.03295896444114105\ \(0\)\
\-\ heroin\\:\\ 0\\.03295896444114105\ \(0\)\
\-\ amphetamines\\:\\ 0\\.03295896444114105\ \(0\)\
\-\ bernstein\\:\\ 0\\.03295896444114105\ \(0\)\
\-\ otherwise\\:\\ 0\\.032663035920056406\ \(0\)\
\-\ vasculopathy\\:\\ 0\\.03222669999040616\ \(0\)\
\-\ 184\\:\\ 0\\.03222669999040616\ \(0\)\
\-\ biopsy\\:\\ 0\\.03211907817418044\ \(0\)\
\-\ within\\:\\ 0\\.031655797688149315\ \(0\)\
\-\ side\\:\\ 0\\.031654632641099766\ \(0\)\
\-\ treatable\\:\\ 0\\.03160757921895683\ \(0\)\
\-\ vasoconstriction\\:\\ 0\\.03160757921895683\ \(0\)\
\-\ elevated\\:\\ 0\\.031236971593331428\ \(0\)\
\-\ 158\\:\\ 0\\.03107127241247994\ \(0\)\
\-\ azathioprine\\:\\ 0\\.03107127241247994\ \(0\)\
\-\ fitting\\:\\ 0\\.03107127241247994\ \(0\)\
\-\ cocaine\\:\\ 0\\.03059821628336691\ \(0\)\
\-\ photon\\:\\ 0\\.03059821628336691\ \(0\)\
\-\ bilaterally\\:\\ 0\\.030559486979682738\ \(0\)\
\-\ g1p1\\:\\ 0\\.030175053156175576\ \(0\)\
\-\ several\\:\\ 0\\.030063249835142067\ \(0\)\
\-\ further\\:\\ 0\\.02984416343627346\ \(0\)\
\-\ superior\\:\\ 0\\.029790312932847587\ \(0\)\
\-\ frontal\\:\\ 0\\.02949179685447745\ \(0\)\
\-\ immunoglobulin\\:\\ 0\\.02944278870544069\ \(0\)\
\-\ nodosa\\:\\ 0\\.02944278870544069\ \(0\)\
\-\ emission\\:\\ 0\\.02912131037670892\ \(0\)\
\-\ erythrocyte\\:\\ 0\\.02912131037670892\ \(0\)\
\-\ disease\\:\\ 0\\.02885121354077378\ \(0\)\
\-\ vasospasm\\:\\ 0\\.028823667933991357\ \(0\)\
\-\ flight\\:\\ 0\\.028287361127514468\ \(0\)\
\-\ takayasu\\:\\ 0\\.028287361127514468\ \(0\)\
\-\ intracerebral\\:\\ 0\\.028287361127514468\ \(0\)\
\-\ primary\\:\\ 0\\.028175139362319034\ \(0\)\
\-\ demonstrated\\:\\ 0\\.028160521214499058\ \(0\)\
\-\ normal\\:\\ 0\\.028062777444617357\ \(0\)\
\-\ weekly\\:\\ 0\\.028043872336742506\ \(0\)\
\-\ variation\\:\\ 0\\.028043872336742506\ \(0\)\
\-\ brant\\:\\ 0\\.028043872336742506\ \(0\)\
\-\ be\\:\\ 0\\.02788178759626812\ \(0\)\
\-\ international\\:\\ 0\\.02781430499840144\ \(0\)\
\-\ for\\:\\ 0\\.02777615203093889\ \(0\)\
\-\ helms\\:\\ 0\\.02759715292498544\ \(0\)\
\-\ erythematosus\\:\\ 0\\.027195184226952107\ \(0\)\
\-\ 3d\\:\\ 0\\.027008344259720145\ \(0\)\
\-\ ht\\:\\ 0\\.026829811089668754\ \(0\)\
\-\ authors\\:\\ 0\\.026829811089668754\ \(0\)\
\-\ sedimentation\\:\\ 0\\.026829811089668754\ \(0\)\
\-\ investigation\\:\\ 0\\.026829811089668754\ \(0\)\
\-\ fundamentals\\:\\ 0\\.026829811089668754\ \(0\)\
\-\ vol\\:\\ 0\\.026829811089668754\ \(0\)\
\-\ 10\\:\\ 0\\.02679395291747607\ \(0\)\
\-\ bmi\\:\\ 0\\.026658877420475218\ \(0\)\
\-\ sylvian\\:\\ 0\\.026658877420475218\ \(0\)\
\-\ tested\\:\\ 0\\.026658877420475218\ \(0\)\
\-\ blood\\:\\ 0\\.026611245950370628\ \(0\)\
\-\ channel\\:\\ 0\\.02649492261490574\ \(0\)\
\-\ lobe\\:\\ 0\\.02647985362290884\ \(0\)\
\-\ axial\\:\\ 0\\.02646801475560709\ \(0\)\
\-\ significant\\:\\ 0\\.026456193311221565\ \(0\)\
\-\ feb\\:\\ 0\\.026337399091743447\ \(0\)\
\-\ history\\:\\ 0\\.02625956805295387\ \(0\)\
\-\ cell\\:\\ 0\\.026211878939042962\ \(0\)\
\-\ worst\\:\\ 0\\.026185821291362193\ \(0\)\
\-\ spect\\:\\ 0\\.026185821291362193\ \(0\)\
\-\ description\\:\\ 0\\.026185821291362193\ \(0\)\
\-\ opposed\\:\\ 0\\.026039756649025886\ \(0\)\
\-\ evidence\\:\\ 0\\.02600822287540566\ \(0\)\
\-\ signal\\:\\ 0\\.025974776595258115\ \(0\)\
\-\ methotrexate\\:\\ 0\\.025762658164170855\ \(0\)\
\-\ carcinomas\\:\\ 0\\.02563096325095603\ \(0\)\
\-\ looking\\:\\ 0\\.02563096325095603\ \(0\)\
\-\ autoimmune\\:\\ 0\\.02563096325095603\ \(0\)\
\-\ anterior\\:\\ 0\\.025583920955844663\ \(0\)\
\-\ wt\\:\\ 0\\.025503449842548997\ \(0\)\
\-\ cessation\\:\\ 0\\.025503449842548997\ \(0\)\
\-\ linked\\:\\ 0\\.02525996105177703\ \(0\)\
\-\ more\\:\\ 0\\.02516077949842746\ \(0\)\
\-\ lyme\\:\\ 0\\.025143537392721522\ \(0\)\
\-\ is\\:\\ 0\\.025096933540008987\ \(0\)\
\-\ lippincott\\:\\ 0\\.02503039371343597\ \(0\)\
\-\ scanning\\:\\ 0\\.024920350254300564\ \(0\)\
\-\ wilkins\\:\\ 0\\.024920350254300564\ \(0\)\
\-\ corticosteroids\\:\\ 0\\.024813241640019967\ \(0\)\
\-\ increased\\:\\ 0\\.024777965300970848\ \(0\)\
\-\ established\\:\\ 0\\.024708915384704197\ \(0\)\
\-\ basis\\:\\ 0\\.024508056781930687\ \(0\)\
\-\ modalities\\:\\ 0\\.024508056781930687\ \(0\)\
\-\ gram\\:\\ 0\\.024411272941986636\ \(0\)\
\-\ sle\\:\\ 0\\.024316766581550787\ \(0\)\
\-\ benefit\\:\\ 0\\.024316766581550787\ \(0\)\
\-\ prominence\\:\\ 0\\.02422443297475467\ \(0\)\
\-\ resonance\\:\\ 0\\.024045899804703282\ \(0\)\
\-\ williams\\:\\ 0\\.024045899804703282\ \(0\)\
\-\ tissue\\:\\ 0\\.024036806728767283\ \(0\)\
\-\ or\\:\\ 0\\.023910607160572233\ \(0\)\
\-\ projection\\:\\ 0\\.023874966135509747\ \(0\)\
\-\ lupus\\:\\ 0\\.023874966135509747\ \(0\)\
\-\ hypertensive\\:\\ 0\\.023792152170537303\ \(0\)\
\-\ treatments\\:\\ 0\\.02371101132994027\ \(0\)\
\-\ lbs\\:\\ 0\\.02363147734473778\ \(0\)\
\-\ magnetic\\:\\ 0\\.02363147734473778\ \(0\)\
\-\ this\\:\\ 0\\.02361752158013945\ \(0\)\
\-\ sulci\\:\\ 0\\.023553487806777976\ \(0\)\
\-\ syndromes\\:\\ 0\\.023553487806777976\ \(0\)\
\-\ affects\\:\\ 0\\.02347698387453331\ \(0\)\
\-\ journal\\:\\ 0\\.023255845364060414\ \(0\)\
\-\ treat\\:\\ 0\\.02318475793298072\ \(0\)\
\-\ provide\\:\\ 0\\.02318475793298072\ \(0\)\
\-\ philadelphia\\:\\ 0\\.02318475793298072\ \(0\)\
\-\ exam\\:\\ 0\\.023066451469070222\ \(0\)\
\-\ rbc\\:\\ 0\\.02304624989683423\ \(0\)\
\-\ med\\:\\ 0\\.02304624989683423\ \(0\)\
\-\ females\\:\\ 0\\.02304624989683423\ \(0\)\
\-\ case\\:\\ 0\\.02302010901354946\ \(0\)\
\-\ ruled\\:\\ 0\\.022912359665168962\ \(0\)\
\-\ 2006\\:\\ 0\\.02284705196599056\ \(0\)\
\-\ branches\\:\\ 0\\.022719538557583525\ \(0\)\
\-\ ra\\:\\ 0\\.022657268550473612\ \(0\)\
\-\ findings\\:\\ 0\\.02261463585440716\ \(0\)\
\-\ multiple\\:\\ 0\\.02241218160932199\ \(0\)\
\-\ fissure\\:\\ 0\\.02235962610775605\ \(0\)\
\-\ probably\\:\\ 0\\.0222464824284705\ \(0\)\
\-\ make\\:\\ 0\\.0222464824284705\ \(0\)\
\-\ 98\\:\\ 0\\.02219108382595385\ \(0\)\
\-\ ua\\:\\ 0\\.021873839904578037\ \(0\)\
\-\ depending\\:\\ 0\\.021823319301279162\ \(0\)\
\-\ 2005\\:\\ 0\\.021773426299357468\ \(0\)\
\-\ daily\\:\\ 0\\.021724145496965216\ \(0\)\
\-\ nuclear\\:\\ 0\\.021675462052349787\ \(0\)\
\-\ cta\\:\\ 0\\.021579830510507197\ \(0\)\
\-\ delivery\\:\\ 0\\.021532855296585315\ \(0\)\
\-\ relief\\:\\ 0\\.021486423160888196\ \(0\)\
\-\ dose\\:\\ 0\\.021395138890480826\ \(0\)\
\-\ setting\\:\\ 0\\.021305883328289393\ \(0\)\
\-\ standard\\:\\ 0\\.02126198851973781\ \(0\)\
\-\ need\\:\\ 0\\.021091054850544275\ \(0\)\
\-\ rr\\:\\ 0\\.02104943442622307\ \(0\)\
\-\ diseases\\:\\ 0\\.02104943442622307\ \(0\)\
\-\ help\\:\\ 0\\.02104943442622307\ \(0\)\
\-\ characteristics\\:\\ 0\\.02100824088557183\ \(0\)\
\-\ leukemia\\:\\ 0\\.0209271000449748\ \(0\)\
\-\ complaining\\:\\ 0\\.0207311424007168\ \(0\)\
\-\ calcium\\:\\ 0\\.02069307258956784\ \(0\)\
\-\ african\\:\\ 0\\.02069307258956784\ \(0\)\
\-\ options\\:\\ 0\\.02065536024671203\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.020617998721431247\ \(0\)\
\-\ times\\:\\ 0\\.020617998721431247\ \(0\)\
\-\ highly\\:\\ 0\\.020507955262295843\ \(0\)\
\-\ giant\\:\\ 0\\.020436233088424613\ \(0\)\
\-\ catheter\\:\\ 0\\.020365769263433448\ \(0\)\
\-\ infections\\:\\ 0\\.020228445288322978\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.020194835594239912\ \(0\)\
\-\ therefore\\:\\ 0\\.020194835594239912\ \(0\)\
\-\ steroids\\:\\ 0\\.020128448380203487\ \(0\)\
\-\ felt\\:\\ 0\\.020128448380203487\ \(0\)\
\-\ recently\\:\\ 0\\.019998877949981914\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.019873357265508144\ \(0\)\
\-\ hr\\:\\ 0\\.01969213848184609\ \(0\)\
\-\ deficits\\:\\ 0\\.01969213848184609\ \(0\)\
\-\ control\\:\\ 0\\.01957571482279058\ \(0\)\
\-\ american\\:\\ 0\\.01954712868784286\ \(0\)\
\-\ distribution\\:\\ 0\\.019434776326657608\ \(0\)\
\-\ healthy\\:\\ 0\\.019434776326657608\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.01940717254098838\ \(0\)\
\-\ medications\\:\\ 0\\.01921908235273306\ \(0\)\
\-\ worse\\:\\ 0\\.019192917211300616\ \(0\)\
\-\ apparent\\:\\ 0\\.019166921424720724\ \(0\)\
\-\ necessary\\:\\ 0\\.019166921424720724\ \(0\)\
\-\ seizure\\:\\ 0\\.019064588882528585\ \(0\)\
\-\ 39\\:\\ 0\\.019039408016313687\ \(0\)\
\-\ needed\\:\\ 0\\.01891581872644559\ \(0\)\
\-\ arthritis\\:\\ 0\\.018633854904829508\ \(0\)\
\-\ bp\\:\\ 0\\.018588727070447748\ \(0\)\
\-\ four\\:\\ 0\\.01856635188720066\ \(0\)\
\-\ before\\:\\ 0\\.01852197204332392\ \(0\)\
\-\ etiology\\:\\ 0\\.018456308428065258\ \(0\)\
\-\ best\\:\\ 0\\.018434656973985837\ \(0\)\
\-\ oral\\:\\ 0\\.018349199813784665\ \(0\)\
\-\ radiology\\:\\ 0\\.018349199813784665\ \(0\)\
\-\ amount\\:\\ 0\\.018328116641984943\ \(0\)\
\-\ condition\\:\\ 0\\.0183071435655788\ \(0\)\
\-\ located\\:\\ 0\\.018123157122449177\ \(0\)\
\-\ csf\\:\\ 0\\.018103224897891478\ \(0\)\
\-\ not\\:\\ 0\\.018089148388803825\ \(0\)\
\-\ occurs\\:\\ 0\\.01806365477480684\ \(0\)\
\-\ includes\\:\\ 0\\.017815536202536505\ \(0\)\
\-\ typical\\:\\ 0\\.0177059930031022\ \(0\)\
\-\ single\\:\\ 0\\.017616935363049778\ \(0\)\
\-\ currently\\:\\ 0\\.017599358376549197\ \(0\)\
\-\ pa\\:\\ 0\\.017581857978467976\ \(0\)\
\-\ hypertension\\:\\ 0\\.0175298097122042\ \(0\)\
\-\ diagnostic\\:\\ 0\\.01746144491257331\ \(0\)\
\-\ aneurysm\\:\\ 0\\.017444534003357506\ \(0\)\
\-\ enhanced\\:\\ 0\\.017444534003357506\ \(0\)\
\-\ are\\:\\ 0\\.017387088955033523\ \(0\)\
\-\ 18\\:\\ 0\\.01736103130735275\ \(0\)\
\-\ rate\\:\\ 0\\.01736103130735275\ \(0\)\
\-\ rare\\:\\ 0\\.017295457034318007\ \(0\)\
\-\ classic\\:\\ 0\\.017136057741678902\ \(0\)\
\-\ headaches\\:\\ 0\\.01708944598054267\ \(0\)\
\-\ like\\:\\ 0\\.017028126697784477\ \(0\)\
\-\ developed\\:\\ 0\\.016997814591600442\ \(0\)\
\-\ commonly\\:\\ 0\\.016952771110080905\ \(0\)\
\-\ management\\:\\ 0\\.01692302034437844\ \(0\)\
\-\ throughout\\:\\ 0\\.01684959352773309\ \(0\)\
\-\ studies\\:\\ 0\\.016806173266946587\ \(0\)\
\-\ middle\\:\\ 0\\.016383010139755252\ \(0\)\
\-\ care\\:\\ 0\\.01637007507219755\ \(0\)\
\-\ typically\\:\\ 0\\.016083517277744375\ \(0\)\
\-\ weight\\:\\ 0\\.015976725122117775\ \(0\)\
\-\ labs\\:\\ 0\\.015872699119858256\ \(0\)\
\-\ benign\\:\\ 0\\.01573806075835845\ \(0\)\
\-\ left\\:\\ 0\\.015630635394230534\ \(0\)\
\-\ cause\\:\\ 0\\.015607789824951163\ \(0\)\
\-\ although\\:\\ 0\\.01559712226222548\ \(0\)\
\-\ first\\:\\ 0\\.015460962273503421\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.015339245837483709\ \(0\)\
\-\ study\\:\\ 0\\.015279743489841369\ \(0\)\
\-\ white\\:\\ 0\\.015115788684271892\ \(0\)\
\-\ out\\:\\ 0\\.015059484000405684\ \(0\)\
\-\ past\\:\\ 0\\.014913086563189534\ \(0\)\
\-\ known\\:\\ 0\\.014833024078084305\ \(0\)\
\-\ found\\:\\ 0\\.014824225969407032\ \(0\)\
\-\ such\\:\\ 0\\.014737288916964223\ \(0\)\
\-\ image\\:\\ 0\\.014652193890523869\ \(0\)\
\-\ during\\:\\ 0\\.014511545749352534\ \(0\)\
\-\ some\\:\\ 0\\.014415149082012543\ \(0\)\
\-\ treated\\:\\ 0\\.014267100574481495\ \(0\)\
\-\ artery\\:\\ 0\\.014229030763332533\ \(0\)\
\-\ syndrome\\:\\ 0\\.013811934608601638\ \(0\)\
\-\ appearance\\:\\ 0\\.013811934608601638\ \(0\)\
\-\ focal\\:\\ 0\\.013704107058490771\ \(0\)\
\-\ edema\\:\\ 0\\.013664406553968183\ \(0\)\
\-\ head\\:\\ 0\\.013664406553968183\ \(0\)\
\-\ lymphoma\\:\\ 0\\.013644702499704581\ \(0\)\
\-\ time\\:\\ 0\\.013579711842061302\ \(0\)\
\-\ presented\\:\\ 0\\.013360185346462583\ \(0\)\
\-\ been\\:\\ 0\\.013347996156514644\ \(0\)\
\-\ months\\:\\ 0\\.013335843847681909\ \(0\)\
\-\ enhancement\\:\\ 0\\.013186963384544477\ \(0\)\
\-\ high\\:\\ 0\\.013020904500516805\ \(0\)\
\-\ who\\:\\ 0\\.01295967020966443\ \(0\)\
\-\ both\\:\\ 0\\.01277609606622875\ \(0\)\
\-\ symptoms\\:\\ 0\\.012535402327960531\ \(0\)\
\-\ associated\\:\\ 0\\.012075623351451521\ \(0\)\
\-\ can\\:\\ 0\\.01202277607576287\ \(0\)\
\-\ most\\:\\ 0\\.011923388857967903\ \(0\)\
\-\ demonstrate\\:\\ 0\\.011910604756972342\ \(0\)\
\-\ large\\:\\ 0\\.011479366028870251\ \(0\)\
\-\ lateral\\:\\ 0\\.011370045610230469\ \(0\)\
\-\ but\\:\\ 0\\.011329345413890171\ \(0\)\
\-\ female\\:\\ 0\\.011055438686091967\ \(0\)\
\-\ presents\\:\\ 0\\.011021198623599645\ \(0\)\
\-\ also\\:\\ 0\\.010776506676893248\ \(0\)\
\-\ images\\:\\ 0\\.010597694565632238\ \(0\)\
\-\ has\\:\\ 0\\.010464911067235225\ \(0\)\
\-\ which\\:\\ 0\\.010417694241224773\ \(0\)\
\-\ by\\:\\ 0\\.009729184898003\ \(0\)\
\-\ there\\:\\ 0\\.00911607105109632\ \(0\)\
